HomeCompareCLXT vs JEPQ

CLXT vs JEPQ: Dividend Comparison 2026

CLXT yields 31.75% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLXT wins by $101.5K in total portfolio value
10 years
CLXT
CLXT
● Live price
31.75%
Share price
$6.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$146.3K
Annual income
$20,332.14
Full CLXT calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — CLXT vs JEPQ

📍 CLXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLXTJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLXT + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLXT pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLXT
Annual income on $10K today (after 15% tax)
$2,698.41/yr
After 10yr DRIP, annual income (after tax)
$17,282.32/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, CLXT beats the other by $15,452.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLXT + JEPQ for your $10,000?

CLXT: 50%JEPQ: 50%
100% JEPQ50/50100% CLXT
Portfolio after 10yr
$95.6K
Annual income
$11,242.36/yr
Blended yield
11.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLXT right now

CLXT
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Altman Z
-4.9
Piotroski
3/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLXT buys
0
JEPQ buys
0
No recent congressional trades found for CLXT or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLXTJEPQ
Forward yield31.75%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$146.3K$44.8K
Annual income after 10y$20,332.14$2,152.59
Total dividends collected$102.0K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CLXT vs JEPQ ($10,000, DRIP)

YearCLXT PortfolioCLXT Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$13,875$3,174.60$11,930$1,110.39+$1.9KCLXT
2$18,962$4,116.48$14,133$1,224.34+$4.8KCLXT
3$25,548$5,257.91$16,632$1,340.46+$8.9KCLXT
4$33,956$6,620.46$19,454$1,457.97+$14.5KCLXT
5$44,557$8,223.86$22,626$1,576.08+$21.9KCLXT
6$57,761$10,085.28$26,175$1,694.09+$31.6KCLXT
7$74,023$12,218.70$30,133$1,811.32+$43.9KCLXT
8$93,839$14,634.31$34,531$1,927.17+$59.3KCLXT
9$117,746$17,338.22$39,403$2,041.08+$78.3KCLXT
10$146,321$20,332.14$44,787$2,152.59+$101.5KCLXT

CLXT vs JEPQ: Complete Analysis 2026

CLXTStock

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Full CLXT Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this CLXT vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLXT vs SCHDCLXT vs JEPICLXT vs OCLXT vs KOCLXT vs MAINCLXT vs XYLDCLXT vs QYLDCLXT vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.